News for 'drug control'

Sameer Wankhede moves HC to seek quashing of CBI FIR

Sameer Wankhede moves HC to seek quashing of CBI FIR

Rediff.com19 May 2023

Former Narcotics Control Bureau (NCB) zonal director Sameer Wankhede on Friday moved a petition before the Bombay high court seeking quashing of a first information report (FIR) filed against him by the Central Bureau of Investigation (CBI) for allegedly demanding Rs 25 crore bribe from superstar Shah Rukh Khan for not implicating his son Aryan Khan in the Cordelia cruise drug bust case.

355 life saving drugs may become cheaper

355 life saving drugs may become cheaper

Rediff.com30 Nov 2007

The government is actively considering bringing 355 life saving drugs under price control and take a few additional measures to help the poor and below poverty line (BPL) families, once the Union Cabinet approves National Pharmaceutical Policy.

No pre-arrest bail to accused Sam D'Souza in Cordelia bribery case

No pre-arrest bail to accused Sam D'Souza in Cordelia bribery case

Rediff.com14 Jun 2023

D'Souza's anticipatory bail plea was rejected by special CBI judge S M Menjonge.

When sportsmen and the drug mafia made for strange bedfellows

When sportsmen and the drug mafia made for strange bedfellows

Rediff.com11 Aug 2017

Rediff.com lists those sportsmen who have been accused of 'sleeping with the enemy'

Bharat Biotech to supply 500 mn Covaxin jabs to Centre

Bharat Biotech to supply 500 mn Covaxin jabs to Centre

Rediff.com23 Jul 2021

Speaking at a virtual conference organised by the Confederation of Indian Industry, Suchitra Ella, joint Managing Director of the city-based vaccine maker, said the company's facilities in four cities -- Hyderabad, Bengaluru, Pune and Ankaleshwar -- are currently producing Covaxin.

Validation check imposed on medicine exports

Validation check imposed on medicine exports

Rediff.com5 Aug 2009

Pharma industry lauds idea, but suggests looser rules on ground

FDA asks stent makers to get DGCI approval

FDA asks stent makers to get DGCI approval

Rediff.com13 Jun 2005

Acting swiftly on the controversy regarding illegal drug-coated stents, the Maharashtra Food and Drug Administration has asked all stent manufacturers and importers to get valid licenses within the next two months from the Drugs Controller General of

India-made Remdesivir may come out in 10 days

India-made Remdesivir may come out in 10 days

Rediff.com19 Jun 2020

The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das.

Now, bulk drug prices to come under NPPA lens

Now, bulk drug prices to come under NPPA lens

Rediff.com16 Feb 2008

NPPA will begin analysing pricing trends of 74 bulk drugs that come under the government-notified price-controlled list every quarter.

Alembic to expand bulk drugs business in US

Alembic to expand bulk drugs business in US

Rediff.com22 May 2003

Indian drug maker Alembic Ltd plans to expand its bulk drugs business in the United States by joining hands with US formulations makers, the Bombay Stock Exchange said on Thursday.

Uzbekistan cough syrup deaths: Noida firm loses production licence

Uzbekistan cough syrup deaths: Noida firm loses production licence

Rediff.com12 Jan 2023

A team of central agencies and the Uttar Pradesh drug department had carried out an inspection at the firm's office in Noida on December 29 and taken six more samples for testing.

Sun Pharma buys controlling stake in Taro

Sun Pharma buys controlling stake in Taro

Rediff.com22 Sep 2010

Sun Pharmaceuticals on Wednesday said it has acquired a controlling stake in Israeli pharma major Taro Pharmaceuticals.

Govt places urgent orders for 11.45 cr HCQ tablets

Govt places urgent orders for 11.45 cr HCQ tablets

Rediff.com2 May 2020

A senior official at the health ministry told ANI: "For HCQ, we have placed orders for about 11.45 crore tablets to two Indian firms -- IPCA laboratories and Zydus Cadila. So far, we have received 6.64 crore HCQ drugs and remaining will arrive by May 16."

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Rediff.com19 Sep 2020

"The phase-III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. "Around 150 to 200 volunteers will be administered the vaccine candidate dose," Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe said.

Ranbaxy loses exclusivity on heartburn drug in US

Ranbaxy loses exclusivity on heartburn drug in US

Rediff.com28 Jan 2015

FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

How Vicks Vaporub Become A Blockbuster

How Vicks Vaporub Become A Blockbuster

Rediff.com31 Oct 2023

Within six months, outlets carrying Vicks jumped from 60,000 pharmacies to 750,000 general stores. The trade boycott collapsed. Consumers were happy, finding Vicks now at every street corner. A fascinating excerpt from Gurcharan Das's Another Sort of Freedom.

India gets 3rd vaccine as DCGI approves Sputnik V

India gets 3rd vaccine as DCGI approves Sputnik V

Rediff.com13 Apr 2021

According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Rediff.com28 Dec 2021

Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday.

1 dead in Aurangabad violence, 7 held for attack on police station

1 dead in Aurangabad violence, 7 held for attack on police station

Rediff.com31 Mar 2023

Normalcy returned to the city, recently renamed as 'Chhatrapati Sambhajinagar', even as the government deployed five companies of the State Reserve Police Force as a precaution.

Poonawala's Serum Inst to soon launch India's first cervical cancer vaccine

Poonawala's Serum Inst to soon launch India's first cervical cancer vaccine

Rediff.com1 Sep 2022

India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an affordable price range of Rs 200-400, Serum Institute of India CEO Adar Poonawalla said on Thursday.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

US bans import of 30 generic drugs of Ranbaxy

US bans import of 30 generic drugs of Ranbaxy

Rediff.com17 Sep 2008

The United States Food and Drug Administration on Tuesday banned the import of more than 30 generic drugs manufactured by Ranbaxy Laboratories Limited alleging that poor quality control at the firm's factories could be harmful to users of these medications used to treat everything from high cholesterol to Type 2 diabetes to everyday allergies.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

Druggies in Punjab spend Rs 2.5 crore a day on drugs!

Druggies in Punjab spend Rs 2.5 crore a day on drugs!

Rediff.com20 Jan 2016

2.3 million people are opioid-dependent. 860,000 people are opioid users. 123,000 people are heroin-dependent.

Pneumonia outbreak in China: Centre asks states to...

Pneumonia outbreak in China: Centre asks states to...

Rediff.com26 Nov 2023

The Union health ministry has advised states to immediately review public health preparedness in view of recent reports indicating a surge in respiratory illness in children in northern China.

Kejriwal needs no insulin: Tihar; Wife says they want to kill him

Kejriwal needs no insulin: Tihar; Wife says they want to kill him

Rediff.com21 Apr 2024

The Aam Aadmi Party on Sunday said Tihar authorities were 'lying' about specialist doctors examining Delhi Chief Minister Arvind Kejriwal, while his wife Sunita Kejriwal alleged that he was being denied insulin for diabetes as 'they want to kill' him.

Drugs worth Rs 27.5 lakh seized in Guwahati

Drugs worth Rs 27.5 lakh seized in Guwahati

Rediff.com15 Jul 2014

Sleuths from the Narcotics Control Bureau on Tuesday seized contraband drug worth over Rs 27.5 lakh in two separate operations carried out in Guwahati and arrested a total of 5 people, including 3 from Manipur.

Rhea-Sara Miss Sushant On 3rd Death Anniversary

Rhea-Sara Miss Sushant On 3rd Death Anniversary

Rediff.com14 Jun 2023

Sushant Singh Rajput passed away on June 14, 2020.

Pharma units face heat

Pharma units face heat

Rediff.com8 Aug 2005

Pharmaceutical companies that have failed to meet the deadline -- which expired on July 1 -- to comply with Schedule M of the Drugs & Cosmetics Act will find the going tough in the days ahead.

WHO gives India five more mths to upgrade standard

WHO gives India five more mths to upgrade standard

Rediff.com3 Oct 2008

The World Health Organization has given five more months to the Drugs Controller General of India to upgrade its performance to international standards. The extension of the current deadline of October-end came after a visiting WHO team found the modernisation programmes of the Indian drug regulator on track.

NCB team to monitor probe into drug bust

NCB team to monitor probe into drug bust

Rediff.com24 May 2003

Customs officials had busted an international drug racket at the flat of a former CBI senior officer, U N Biswas.

Drug firms knock on PM's door

Drug firms knock on PM's door

Rediff.com8 Sep 2004

Israel defends bombing ambulance in Gaza, says it was used by Hamas

Israel defends bombing ambulance in Gaza, says it was used by Hamas

Rediff.com4 Nov 2023

Israel claimed responsibility for the attack on an ambulance outside Gaza City's Al Shifa Hospital which killed several people and left dozens more wounded, CNN reported on Friday.

Hetero to launch Remdesivir as Covifor this week

Hetero to launch Remdesivir as Covifor this week

Rediff.com22 Jun 2020

The Hyderabad-based firm will first make the drug available in high case load areas of Maharashtra and Delhi under the brand Covifor. A single dose vial is likely to cost Rs 5,000-6000.

COVID-19 in India: Nobody is really in control

COVID-19 in India: Nobody is really in control

Rediff.com26 Jun 2020

When BJP leaders, including Mr Modi's number two, Amit Shah, use the pandemic to launch an assault on state governments run by opposition parties, or to topple them, they are exploiting a grave crisis in cynical political self-interest, notes Shekhar Gupta.

After flak for Aryan case, Wankhede transferred to Chennai

After flak for Aryan case, Wankhede transferred to Chennai

Rediff.com31 May 2022

The NCB, which recently filed a charge-sheet in the drugs-on-cruise case, gave a clean chit to Aryan Khan.

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'